Clinical Trials Directory

Trials / Completed

CompletedNCT01049711

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

Cost-Utility Analysis of Erythropoietin for Anemia Treatmentin Thai End-Stage Renal Disease Patients With Hemodialysis

Status
Completed
Phase
Study type
Observational
Enrollment
152 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

To study the cost utility analysis of Erythropoietin (EPO) for maintaining the different hemoglobin (Hb) target levels in anemic hemodialysis patient in routine clinical practice.

Detailed description

In Thailand, the studies that were conducted to find the most useful target Hb have not included the cost effectiveness and/or cost utility analyses. The level at which quality of life is maximized and risk is minimized would be the optimal target. Dialysis patients carry higher risk of death than general population. Anemia is the common complication found in dialysis patients that could lead to mortality. Risk of anemia is occurred in HD patients more than CAPD patients because blood loss is less marked and residual renal function maybe better preserved in patients who receive peritoneal dialysis.Although EPO has been included in the National List of Essential Drugs (NLED) for the treatment of anemia caused by end stage renal disease for maintaining the target hemoglobin but the cost of EPO is so expensive. Cost utility analysis is economic technique for assessing the efficiency of healthcare intervention measuring combined outcomes as the effectiveness, i.e., survival and quality of life in combination as quality adjusted life years (QALYs).This study is a benefit measure at the care giving level by using as a part of planning patient management program and at the policy level for decision making.

Conditions

Interventions

TypeNameDescription
DRUGerythropoietin

Timeline

Start date
2009-11-01
Primary completion
2010-02-01
Completion
2010-09-01
First posted
2010-01-14
Last updated
2015-09-29

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01049711. Inclusion in this directory is not an endorsement.